1) nedaplation
奈得铂
2) nedaplatin
奈达铂
1.
Low Dose Gemcitabine Combined Nedaplatin for Advanced Nonsmall-cell Lung Cancer:Observation of Curative Effect;
低剂量吉西他滨联合奈达铂治疗晚期非小细胞肺癌疗效观察
2.
Effects of combinative application of nedaplatin and cisplatin on the proliferation and apoptosis of human esophageal squamous carcinoma Eca-109 cell line;
奈达铂与顺铂联合应用对人食管癌Eca-109细胞增殖与凋亡的影响
3.
Mulcenters clinical trial on the treatment of advanced esophageal carcinoma with combination of nedaplatin and cisplatin;
奈达铂联合顺铂治疗晚期食管癌多中心临床研究
3) Nedaplatin(NDP)
奈达铂(NDP)
4) Nedaplatin
含奈达铂
1.
Efficacy of Combined Chemotherapy with Medicines Containing Nedaplatin for Advanced Non-small Cell Lung Cancer
含奈达铂的两药联合治疗晚期非小细胞肺癌的临床观察
5) Triamcinolone acetonide
曲安奈得
1.
Triamcinolone acetonide (TA) suspension with anti-proliferative, anti-edematous, anti-inflammatory and angiostatic effects is increasingly being used for ocular edematous, neovascular and proliferative diseases, in particular of the macula.
目的:具有抗增生、抗水肿、抗炎和血管稳定作用的曲安奈得(TA)混悬液在眼水肿、新生血管和增生性疾病,特别是黄斑疾病的应用正在不断增加。
6) budesonide
布地奈得
1.
A group inhaled 200 μg/d of budesonide,B group inhaled 400 μg/d of budesonide,and C group inhaled 800 μg/d of budesonide.
方法采用随机配对法将确诊的60例CVA并嗜酸细胞性支气管炎(EB)患者分为A、B、C 3组,A组吸入布地奈得200μg/d,B组吸入布地奈得400μg/d,C组吸入布地奈得800μg/d;治疗3个月后,观察治疗前及治疗后的咳嗽症状评分、诱导痰嗜酸细胞计数及症状消失时间。
补充资料：萘达铂
分子式：暂无
分子量：暂无
CAS号：95734-82-0
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：95734-82-0
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条